Endogenous GLP-1 Secretion

Endogenous GLP-1 secretion refers to the body’s natural production and release of Glucagon-Like Peptide-1 (GLP-1) hormones, which manage blood glucose levels, appetite, and digestion.

In the context of the evolving beverage market, functional beverage brands are positioning proprietary ingredient stacks to naturally stimulate this endogenous secretion, aiming to capture consumers shifting away from traditional carbonated-soft-drinks-csd.

A leading clinical hypothesis—currently being tested in trials such as NCT07105826 at texas-christian-university—suggests that prebiotic beverages (like olipop and poppi) enhance satiety and GLP-1 secretion due to their high fiber content. This fiber ferments via the gut microbiota to produce short-chain fatty acids (SCFAs), which naturally trigger GLP-1 release without causing the significant glucose or insulin spikes associated with traditional sodas.

If clinically substantiated, this mechanism offers a physiological explanation for the-diet-soda-paradox, wherein consumers utilizing glp-1-medications are actively abandoning artificial calorie-free sodas in favor of functional prebiotic alternatives that actively support their metabolic goals.